Mfn2 Protein (Mitofusin 2) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mitofusin 2 (MFN2) is a dynamin-like GTPase protein located on the mitochondrial outer membrane that mediates mitochondrial fusion, a critical process in mitochondrial dynamics. As one of the key regulators of mitochondrial morphology and distribution, MFN2 is essential for cellular energy metabolism, calcium homeostasis, and [apoptosis](/entities/apoptosis) regulation. Dysfunction of MFN2 is implicated in Charcot-Marie-Tooth disease type 2A (CMT2A), as well as neurodegenerative diseases including Parkinson's disease and Alzheimer's disease[@cohen2017][@gautam2019].
In [neurons](/entities/neurons), MFN2 facilitates mitochondrial transport along axons via:
Interaction with mitochondrial anchoring proteins
Regulation of mitochondrial motility
Distribution to energy-demanding regions (synapses, Nodes of Ranvier)
Quality Control
MFN2 is involved in mitochondrial quality control through:
Mitophagy: Regulation of PINK1/Parkin-mediated selective mitophagy
ER-Mitochondria Contacts: Formation of mitochondria-ER contacts for calcium exchange
Proteostasis: Targeting damaged mitochondria for degradation[@gautam2019]
Role in Disease
Charcot-Marie-Tooth Disease Type 2A
Pathogenic MFN2 mutations cause CMT2A through loss-of-function mechanisms:
Impaired mitochondrial fusion
Axonal mitochondrial deficiency
Distal axon degeneration
Parkinson's Disease
MFN2 dysfunction contributes to mitochondrial fragmentation in dopaminergic neurons
Impaired PINK1/Parkin mitophagy
Increased vulnerability to mitochondrial toxins (MPTP, rotenone)[@gautam2019]
Alzheimer's Disease
[Aβ](/proteins/amyloid-beta-protein) oligomers alter MFN2 expression and distribution
Mitochondrial transport deficits in cortical neurons
Synaptic mitochondrial dysfunction
Therapeutic Targeting
Key Publications
Cohen Y, et al. (2017). "Structure of the mitofusin 2 transmembrane domain." [Autophagy](/entities/autophagy). PMID: 28368771(https://pubmed.ncbi.nlm.nih.gov/28368771/)[@cohen2017]
Gautam M, et al. (2019). "Mfn2 deficiency is associated with impaired mitophagy and accelerated aging in Parkinson's disease." Autophagy. PMID: 31155716(https://pubmed.ncbi.nlm.nih.gov/31155716/)[@gautam2019]
Rocha A, et al. (2018). "Mutations in MFN2 decrease mitochondrial transport and cause axonal CMT." Brain. PMID: 29378098(https://pubmed.ncbi.nlm.nih.gov/29378098/)
The study of Mfn2 Protein (Mitofusin 2) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Cohen Y, et al, (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/28368771/)
[Gautam M, et al, (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31155716/)